IPSEN (EPA:IPN) Correction: Ipsen announces U.S. FDA submission acceptance of its supplemental New Drug Application for Onivyde regimen in first-line metastatic pancreatic ductal adenocarcinoma
Transparency directive : regulatory news
14/06/2023 22:35